Kerala tops Health Index, Uttar Pradesh worst performer

Agencies
February 9, 2018

New Delhi, Feb 9: Kerala has topped among large states on overall health performance in NITI Aayog's Health Index, while Uttar Pradesh appears at the bottom though it has shown big improvement in the recent past. Kerala was followed by Punjab, Tamil Nadu and Gujarat, according to the report -- 'Healthy States, Progressive India: Report on Rank of States and UTs'.

Rajasthan, Bihar and Odisha are among those which have performed poorly on the index. In terms of annual incremental performance, Jharkhand, Jammu & Kashmir and Uttar Pradesh are the top three states. These three states showed the maximum gains in indicators such as Neonatal Mortality Rate (NMR), Under-five Mortality Rate (U5MR), full immunisation coverage, institutional deliveries.

Among the smaller states, Mizoram ranked first followed by Manipur and Goa. Among Union Territories or UTs, Lakshadweep showed both the best overall performance as well as the highest annual incremental performance. Releasing the report, NITI Aayog CEO Amitabh Kant said the government think tank believes that the Health Index will act as a tool to leverage co-operative and competitive federalism, accelerating the pace of achieving health outcomes. Kant further said: "By June this year, we would take out the ranking of 730 district hospitals based on their performance. We want to encourage the good performers and name and shame those who don't." NITI Aayog member Vinod Kumar Paul said that absolute and incremental changes in health outcomes, as measured by the Health Index, promote cross-learning between states, capturing the very spirit of cooperative & competitive federalism.

Health and Family Welfare Secretary Preeti Sudan said her ministry will soon announce the linked incentives for states which have performed better on Health Index. World Bank India Country Director Junaid Ahmad said that India is the only large country which has done this kind of exercise and the index developed by NITI Aayog and World Bank has global implication. 

According to a NITI Aayog statement, the ranking was done under three categories -- larger states, smaller States and UTs to ensure comparison among similar entities. The three indicators which were factored while ranking the states are Health Outcomes (70 per cent), Governance and Information (12 per cent) and Key Inputs and Processes (18 per cent), with each domain assigned a weight based on its importance. The statement said that there was a large gap in overall performance between the best and the least performing states and UTs.

"In the reference year (2015-16) among the larger states, the index scope for overall performances ranged widely between 33.69 in Uttar Pradesh to 76.55 in Kerala," it said. The Index is expected to nudge states towards further achieving a rapid transformation of their health systems and population health outcomes, it added.

Comments

Bhageeratha Bhaira
 - 
Friday, 9 Feb 2018

Ohhh!!! Modiji’s Somalia tops and Ram Rajya flops...

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 6,2020

Kasaragod, Apr 6: Even as the number of positive cases of Novel Coronovirus is on increase in this district, the ten-member medical team from Thiruvananthapuram on Monday will inspect and review modalities to convert the proposed Kasaragod medical college into a COVID-19 hospital.

Given the constraints being faced by the district hospital in Kanhangad near here, the 200-beded Kasaragod medical college hospital in Ukkinada near here would be equipped to cater to the Covid-19 patients on isolation.

The ten member medical experts who reached here late on Sunday, are on a special mission to immediately equip the hospital as to convert it as a Covid-19 centre.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 26,2020

Mangaluru, Feb 26: Customs officials at Mangalore International Airport on Wednesday arrested a man for trying to smuggle gold worth over Rs 26 lakh by concealing it in his rectum.

The accused has been identified as Moideen Arzan, a resident of Uppala, Kasaragod.

According to police, he arrived from Dubai by an Air India flight and was attempting to smuggle the gold which he had converted in the form of paste and concealed in rubber capsules inside his rectum.

Comments

Azmath
 - 
Thursday, 27 Feb 2020

"Get rich quick and by any means syndrome"
Those Economy Saboteurs/ Smugglers are very Desperate People whose means of livelihood depends Solely on their Criminal Activities. 

 

WHAT is driving these people so crazily into CRIMINALITY?!

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.